NeuroOne Medical Technologies (NASDAQ: NMTC) has submitted a special 510(k) to the U.S. Food and Drug Administration (FDA) for its sEEG electrode to extend the duration of use from less than 24 hours to less than 30 day use.
The FDA has extended the review timeline for Reata Pharmaceuticals Inc’s (NASDAQ:RETA) marketing application seeking approval for omaveloxolone for Friedreich’s ataxia by…
John Lynch, Comerica Wealth Management's Chief Investment Officer, says there has been a growth in the money supply. He says the Fed has measured money supply by M2 that surged to a peak of 25% Y/Y in the summer of 21.